dermatan sulfate has been researched along with Chronic Kidney Failure in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, GJ; McMahon, LP; Polkinghorne, KR | 1 |
| Henny, CP; Ockelford, PA; Surachno, S; Ten Cate, H; Ten Cate, JW; van Bronswijk, H; Wilmink, JM | 1 |
| Greinacher, A; Kemkes-Matthes, B; Möckl, M; Mueller-Eckhardt, C; Philippen, KH; Schaefer, K | 1 |
| Coles, GA; Davies, M; Stylianou, E; Thomas, GJ; Williams, JD; Yung, S | 1 |
| Berckmans, RJ; Büller, HR; Gianese, F; Imbimbo, BP; Nurmohamed, MT; Ten Cate, JW | 1 |
| Bredlich, RO; Gall, H; Proebstle, TM; Stracke, S | 1 |
| Boccardo, P; Boletta, A; Casiraghi, F; Gianese, F; Mecca, G; Melacini, D; Rota, S | 1 |
| Ben Ami, R; Berliner, S; Rachmimov, R | 1 |
| Goetschel, P; Leumann, E; Neuhaus, TJ; Schmugge, M | 1 |
| Boneu, B; Duchêne, P; Ducret, F; Houin, G; Palazzini, E; Pourrat, J; Saivin, S; Zamboni, W | 1 |
| Brouwer, DJ; Peterson, P | 1 |
| Boisclair, M; Curtis, JR; Flynn, A; Ireland, H; Lane, DA; Ryan, KE; Shepperd, J | 1 |
| Alapiessa, U; Harjanne, A; Stiekema, J; Von Bonsdorff, M | 1 |
| Büller, HR; den Hartog, M; Henny, CP; Stevens, P; Surachno, S; ten Cate, H; ten Cate, JW | 1 |
| Anastassiades, E; Curtis, JR; Flynn, A; Ireland, H; Lane, DA | 1 |
7 trial(s) available for dermatan sulfate and Chronic Kidney Failure
| Article | Year |
|---|---|
Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients.
Topics: Anticoagulants; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Enoxaparin; Factor Xa Inhibitors; Female; Heparinoids; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Male; Prospective Studies; Renal Dialysis | 2002 |
The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure.
Topics: Adult; Aged; Blood Coagulation; Blood Platelets; Dermatan Sulfate; Female; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Partial Thromboplastin Time; Renal Dialysis | 1993 |
Individualized anticoagulation with dermatan sulphate for haemodialysis in chronic renal failure.
Topics: Aged; Anticoagulants; Cross-Over Studies; Dermatan Sulfate; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Partial Thromboplastin Time; Renal Dialysis; Thrombosis | 1997 |
Pharmacodynamic study of low molecular weight dermatan sulphate (Desmin) after a single subcutaneous administration in patients with renal insufficiency.
Topics: Adult; Aged; Area Under Curve; Dermatan Sulfate; Factor Xa; Female; Humans; Injections, Subcutaneous; Kidney Failure, Chronic; Male; Middle Aged; Partial Thromboplastin Time; Prothrombin; Thrombin Time | 2000 |
Antithrombotic properties of dermatan sulphate (MF 701) in haemodialysis for chronic renal failure.
Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Blood Coagulation; Dermatan Sulfate; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Fibrinopeptide A; Heparin; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peptide Hydrolases; Renal Dialysis; Thrombosis | 1992 |
A new low molecular weight heparinoid Org 10172 as anticoagulant in hemodialysis.
Topics: Anticoagulants; Bleeding Time; Blood Cell Count; Chondroitin Sulfates; Dermatan Sulfate; Female; Glycosaminoglycans; Heparin; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Partial Thromboplastin Time; Renal Dialysis | 1990 |
The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysis.
Topics: Adult; Aged; Antibodies; Chondroitin Sulfates; Dermatan Sulfate; Factor X; Factor Xa; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Middle Aged; Molecular Weight; Renal Dialysis; Time Factors | 1985 |
8 other study(ies) available for dermatan sulfate and Chronic Kidney Failure
| Article | Year |
|---|---|
Use of a new heparinoid as anticoagulant during acute haemodialysis of patients with bleeding complications.
Topics: Acute Kidney Injury; Adult; Aged; Blood Platelet Disorders; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation; Female; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk | 1983 |
Heparin-associated thrombocytopenia type II in a patient with end-stage renal disease: successful anticoagulation with the low-molecular-weight heparinoid Org 10172 during haemodialysis.
Topics: Aged; Chondroitin Sulfates; Dermatan Sulfate; Female; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Molecular Weight; Renal Dialysis; Thrombocytopenia | 1993 |
Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans.
Topics: Ascitic Fluid; Biglycan; Chondroitin Sulfates; Decorin; Dermatan Sulfate; Epithelium; Extracellular Matrix Proteins; Humans; Kidney Failure, Chronic; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Proteoglycans | 1995 |
[Heparin-associated platelet aggregation syndrome with skin necrosis during hemodialysis].
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Foot Dermatoses; Heparin; Heparinoids; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Necrosis; Platelet Aggregation; Renal Dialysis; Skin; Skin Diseases | 1997 |
[Danaparoid sodium for dialysis in heparin-associated thrombocytopenia].
Topics: Aged; Aged, 80 and over; Antithrombin III; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Male; Nephrotic Syndrome; Platelet Aggregation; Renal Dialysis; Thrombocytopenia | 1999 |
Heparin-induced thrombocytopenia type II on hemodialysis: switch to danaparoid.
Topics: Adolescent; Anticoagulants; Child; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Male; Platelet Count; Renal Dialysis; Thrombocytopenia | 2000 |
Heparin-induced thrombocytopenia in hemodialysis patients.
Topics: Anticoagulants; Body Weight; Chondroitin Sulfates; Contraindications; Dermatan Sulfate; Drug Monitoring; Heparin; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Renal Dialysis; Thrombocytopenia | 2000 |
The anticoagulant effect of heparinoid Org 10172 during haemodialysis: an objective assessment.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Evaluation Studies as Topic; Factor X; Factor Xa; Fibrinopeptide A; Glycosaminoglycans; Heparin; Heparitin Sulfate; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Platelet Aggregation; Renal Dialysis | 1986 |